Definium Therapeutics, Inc. (“Definium” or the “Company”), announced results from a retrospective, longitudinal study published in the Journal of Mood and Anxiety Disorders examining the real-world ...

In recent days, Definium Therapeutics reported a published longitudinal study showing diagnosed generalized anxiety disorder prevalence in U.S. adults rose from 5.4% in 2020 to 6.6% in 2023, alongside ...

In the mental health field, we tend to pathologize and diagnose even commonly encountered challenges. Through the lens of human experience, however, we can recognize that some emotional and mental ...

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six months, have a high relapse rate even after receiving treatment. Artificial ...

In the “ThemenCheck Medizin” procedure offered by the German Institute for Quality and Efficiency in Health Care (IQWiG), interested members of the public can submit proposals for the assessment of ...

Gimel Health addresses this gap through individualized medication management protocols guided by the principles of precision psychiatry and clinical neurobiology. Rather than applying ...

This week, Bobbi Conner talks with MUSC's Dr. Amanda Overstreet about managing anxiety, specifically in the older adult years ...